Clinical trials
Nasopharyngeal Carcinoma trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
233 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 5 |
| 2011 | 6 |
| 2012 | 5 |
| 2013 | 9 |
| 2014 | 9 |
| 2015 | 13 |
| 2016 | 20 |
| 2017 | 16 |
| 2018 | 27 |
| 2019 | 22 |
| 2020 | 21 |
| 2021 | 26 |
| 2022 | 22 |
| 2023 | 14 |
| 2024 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 233 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 68 |
| Zhejiang Cancer Hospital | 16 |
| Fudan University | 13 |
| Fujian Cancer Hospital | 9 |
| Eye & ENT Hospital of Fudan University | 6 |
| Jiangxi Provincial Cancer Hospital | 6 |
| Chinese University of Hong Kong | 4 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 4 |
| Wei Jiang | 4 |
| Yun-fei Xia | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nasopharyngeal Carcinoma | 233 |
| Nasopharyngeal Neoplasms | 14 |
| Head and Neck Neoplasms | 8 |
| Neoplasm Metastasis | 7 |
| Recurrence | 7 |
| Squamous Cell Carcinoma of Head and Neck | 4 |
| Stomatitis | 4 |
| Epstein-Barr Virus Infections | 3 |
| Sarcoma | 3 |
| Stomach Neoplasms | 3 |
Trials
Showing 1 to 25 of 233. Each trial links to its page on Pharma Observatory.
133 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.